Genetic screening of prospective oocyte donors

Fertility and Sterility

Volumn 70, Issue 1, 1998, Pages 52-55

  Wallerstein, Robert ^a,b   Jansen, Valerie ^a   Grifo, Jamie A ^a   Berkeley, Alan S ^a   Noyes, Nicole ^a   Licker, Jennifer ^a   Licciardi, Frederick ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Carrier testing; Genetic screening; Oocyte donation

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; GENETIC SCREENING; HEMOGLOBIN DETERMINATION; HETEROZYGOTE; HUMAN; INFERTILITY; KARYOTYPE; MAJOR CLINICAL STUDY; OOCYTE DONATION; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONDYLOEPIPHYSEAL DYSPLASIA; TAY SACHS DISEASE;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; KARYOTYPING; OOCYTE DONATION; OSTEOCHONDRODYSPLASIAS; RISK FACTORS;

EID: 0032124882     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00109-5     Document Type: Article

References (19)

1. 1. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril 1987;47:895-909.
2. 2. American Fertility Society. New guidelines for use of semen donor insemination: 1990. Fertil Steril 1990;53(Suppl 1):1S-13S.
3. 3. American Fertility Society. Guidelines for gamete donation: 1993. Fertil Steril 1993;59(Suppl 1):1S-9S.
4. 4. Mechanick Braveman A, et al. Survey results on the current practice of ovum donation. Fertil Steril 1993;59:1216-20.
5. 5. National Institutes of Health Consensus Statement. Genetic testing for cystic fibrosis. 1997;15:4.
6. 6. Fraser FC, Force RA. On genetic screening of donors for artificial insemination. Am J Med Genet 1981;10:399-405.
7. 7. Timmons MC, Rao KW, Sloan CS, Krirman HN, Talbert LM. Genetic screening of donors for artificial insemination. Fertil Steril 1981;35: 451-6.
8. 8. Conrad EA, Fine B, Hecht B, Pergament E. Current practices of commercial cryobanks in screening prospective donors for genetic disease and reproductive risk. Int J Fertil 1996;41:298-303.
9. 9. Gardner RJM, Sutherland GR. Chromosome abnormalities and genetic counseling. 2nd ed. New York: Oxford University Press, 1996:143-5.
10. 10. Farrel PM, Mischler EH. Newborn screening for cystic fibrosis. Adv Pediatr 1992;39:31-64.
11. 11. Tsui LC. The spectrum of cystic fibrosis mutations. Trends Genet 1992;8:392-8.
12. 12. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tays-Sachs disease: carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 1993;270:2307-15.
13. 13. Kronn D, Oddoux C, Philips J., Ostrer H. Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population. Am J Hum Genet 1995;57:1250-2.
14. 14. Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, McPherson RA, West C, et al. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 1993;52:85-8.
15. 15. Whitney MA, Jakobs P., Kaback M, Moses RE, Grompe M. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and a carrier frequency in the at-risk population. Hum Mutat 1994;3: 339-41.
16. 16. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, et al. The Bloom syndrome gene product is homologous to RecQ helicases. Cell 1995;83:655-66.
17. 17. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53: 1217-28.
18. 18. Weatherall DJ. The molecular basis of thalassemia. Johns Hopkins Medical Journal 1976;139:205-9.
19. 19. Jones KL, editor. Smith's recognizable patterns of human malformation. 5th ed. Philadelphia: WB Saunders, 1994:358-9.